You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pegasys

Showing 1 - 25 of 440
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

Not yet recruiting
  • Membranous Nephropathy
  • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
  • Nice, France
    CHU de NICE
Jul 4, 2023

Hepatitis D Trial in Athens (Bulevirtide)

Recruiting
  • Hepatitis D
  • Athens, Greece
    Department of Gastroenterology, Medical School of National & Kap
Jun 28, 2023

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

Healthy Participants Trial (BMS-986465, Placebo, Pegasys)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Nov 17, 2023

Hepatitis B, Chronic Trial in Worldwide (peginterferon alfa-2a [Pegasys])

Completed
Has Results
  • Hepatitis B, Chronic
  • peginterferon alfa-2a [Pegasys]
  • San Francisco, California
  • +38 more
Oct 26, 2022

Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Mar 28, 2022

Acute Myeloid Leukemia Trial in Ann Arbor (peg-IFN-a, Hematopoietic Cell Transplant (HCT), Tacrolimus)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Oct 1, 2021

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Chronic Hepatitis Trial in Hangzhou, Shanghai (Group A, TDF, Group B:TDF then TDF and Peginterferon alfa-2a, Group C:TDF and

Recruiting
  • Chronic Hepatitis
  • Group A, TDF
  • +2 more
  • Hangzhou, China
  • +7 more
Sep 21, 2021

Viral Hepatitis B, Viral Hepatitis D, Cirrhosis, Liver Trial in Worldwide (REP 2139-Mg, Tenofovir Disoproxil Fumarate, Pegylated

Available
  • Viral Hepatitis B
  • +6 more
  • REP 2139-Mg
  • +2 more
  • Vienna, Austria
  • +12 more
Feb 1, 2023

Chronic Hepatitis B Trial in Shanghai (Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets)

Not yet recruiting
  • Chronic Hepatitis B
  • Shanghai, Shanghai, China
  • +1 more
Feb 16, 2022

Colon Cancer Trial in Køge (Pegasys, Saline)

Not yet recruiting
  • Colon Cancer
  • Køge, Zealand, Denmark
    Zealand University Hospital
Jun 14, 2021

Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

Completed
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Aug 26, 2021

Hepatitis C, Chronic Trial in Chennai (Sofosbuvir, Pegylated Interferon alfa-2a, Ribavirin)

Completed
Has Results
  • Hepatitis C, Chronic
  • Chennai, Tamil Nadu, India
    YR Gaitonde Centre for AIDS Research and Education
Mar 22, 2021

Hepatitis B Virus Trial in Beijing (Human Serum Albumin/interferon alpha2b fusion protein, Pegasys)

Completed
  • Hepatitis B Virus
  • Human Serum Albumin/interferon alpha2b fusion protein
  • Pegasys
  • Beijing, Beijing, China
    Beijing YouAn Hospital, Capital Medical University
Mar 29, 2021

Hepatitis C, Chronic Trial in Bilaspur (Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a)

Completed
Has Results
  • Hepatitis C, Chronic
  • Bilaspur, Chhattisgarh, India
    YR Gaitonde Centre for AIDS Education and Johns Hopkins Universi
Apr 26, 2021

Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

Completed
  • Hepatitis C, Chronic
  • PEGASYS 180 µg Q1W
  • +3 more
  • Changhua, Taiwan
  • +12 more
Oct 7, 2021

HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

Completed
Has Results
  • HIV Infection
  • Hepatitis C Infection
  • Nitazoxanide (NTZ)
  • +2 more
  • Birmingham, Alabama
  • +17 more
Nov 2, 2021

Chronic Viral Hepatitis B With Delta-agent Trial in Russian Federation (Myrcludex B, PEG IFN alfa-2a, Tenofovir)

Completed
Has Results
  • Chronic Viral Hepatitis B With Delta-agent
  • Myrcludex B
  • +2 more
  • Chelyabinsk, Russian Federation
  • +6 more
Apr 7, 2021

Chronic Hepatitis Trial in Italy (Peginterferon alpha-2a + Ribavirin)

Completed
  • Chronic Hepatitis
  • Peginterferon alpha-2a + Ribavirin
  • Avellino, Italy
  • +34 more
Mar 9, 2022

Hepatitis C Trial in Tanta (Sofosbuvir, Ribavirin, Pegylated-interferon alfa-2a)

Completed
  • Hepatitis C
  • Tanta, Egypt
  • +1 more
Aug 1, 2020

Hepatitis C, Human Immunodeficiency Virus, HIV Trial in San Francisco (Pegylated interferon alfa-2a + Ribavirin)

Completed
Has Results
  • Hepatitis C
  • +2 more
  • Pegylated interferon alfa-2a + Ribavirin
  • San Francisco, California
    San Francisco General Hospital/UCSF
May 14, 2020

Leukemia, Chronic Myeloid Trial in Malaysia (Peginterferon-a-2a)

Active, not recruiting
  • Leukemia, Chronic Myeloid
  • Johor Bahru, Johor, Malaysia
  • +8 more
Sep 11, 2020

Chronic Hepatitis c, Cirrhosis, Liver, Fibrosis, Liver Trial in United States (Peginterferon alfa-2a + Ribavirin, Peginterferon

Completed
Has Results
  • Chronic Hepatitis c
  • +3 more
  • Peginterferon alfa-2a + Ribavirin
  • Peginterferon alfa-2a
  • Long Beach, California
  • +10 more
Apr 29, 2020